News About: Pharm. Industry
Yuyu Sets Revenue Plan of 100 Billion Won by Year 2007
Yuyu Inc. enters the new fiscal year starting April 1st by announcing its strategic plans to become one of the leading pharmaceutical companies in the nation, achieving the revenue of 100 billion won by Year 2007.
...
SK Chemical Renamed as SK Chemicals Life Science
SK Chemical announced that the company is now operating effective April 1st under the new business entity titled SK Chemicals Life Science, upon a successful completion of its merger with SK Pharma.
Under an initia...
Promotion of Wholesale Inventory Returns Eyed
The active level of promotion and acceptance on the return of cumulative pharmaceutical wholesale inventories is drawing attentions from the industry constituents.
The wholesalers stated that one pharmaceutical com...
Three Johnson & Johnson Affiliates Continue Undertaking Social Contribution Activities
Reflective of strong commitments on promoting public health and welfare, three domestic Johnson & Johnson affiliates of Janssen Korea, Johnson & Johnson Korea and Johnson & Johnson Medical Korea are to undertake vario...
Novartis Korea Attains New Indication for Diovan
Novartis Korea announced that it has received an approval by the Korea Food and Drug Administration (KFDA) on the additional indication for Diovan (active ingredient: valsartan) as a first-line, post MI (myocardial in...
AstraZeneca Records Revenue over 100 Billion Won
AstraZeneca Korea recently released the company financial performance for Year 2004, where the total revenue surpassed over the 100 billion won mark for the first time since the merge of two independent subsidiaries, ...
Choongwae Announces KFDA Approval of Extended Indications for Provigil
Choongwae Pharmaceutical announced that the Korea Food and Drug Administration (KFDA) has approved additional therapeutic indications for Provigil (active ingredient: modafinil), which is currently prescribed to over ...
Johnson & Johnson Korea Announces Year 2004 Financial Results
Johnson & Johnson Korea reported its total revenue for Year 2004 at 120 billion won, which is an increase of 13.3% from the prior fiscal period.
Both the company's operating profit and the ordinary profit show a do...
Roche Korea Announces Year 2004 Financial Results
Roche Korea announced the financial results for Year 2004, in which the company recorded the revenue of 91.5 billion won, down 7.97% from the prior fiscal period.
The operating profit was 6.8 billion won, down by 5...
Bayer Korea Denies Allegation Made by Korea Pharmaceutical Association
In response to the recent discovery on the broken tablets of Caldivita, an over-the-counter (OTC) calcium supplement marketed by Bayer Korea, the company stated that the allegations made by the Korea Pharmaceutical As...
